Ovarian Cancer - Pipeline Review, H1 2014

Industry: 

769 Views
Buy This Report

Ovarian Cancer - Pipeline Review, H1 2014 report provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

  • 769 reads